Medical Observer - Information is our Prescription

About Us      Contact Us      Our Services      Press Room      Careers

 

Front-page

Heard and Read

NIH Forum

In the News

Meeting Highlights

Ethics

Special Report

Genetics

Cover to Cover

Reel World

Cancer Watch

New Frontiers

Aids Watch

Drug Updates

Industry News

Organized Medicine

UN Health

 

CME Calendar

Local
Conventions

Overseas
Conventions

powered by: FreeFind

June 2007

May 2007

More Issues
Medical Tourism Asia

Mailing List
Receive updates from Medical Observer

Name
Email
Specialty
PRC Lic.

 
 
 

Neurology

Galantamine Edge in AD

Galantamine (Reminyl) exhibits a superior treatment profile than donepezil (Aricept) for patients with Alzheimer's Disease, according to results of the first one-year head to head study of the two drugs.

More on this Story

Piracetam Is Neuroprotective

Cerebrovascular disease is now the leading cause of morbidity and mortality worldwide. It is also the most common cause of chronic disability.  

More on this Story

Recovering from Ischemic Stroke

Oral citicoline ups odds of favorable outcome by 33% after 12 weeks of treatment, meta-analysis shows.  

More on this Story

 

Updated last July 28, 2007 , Developed and Maintained by JML Internet Solutions
Best viewed with Microsoft Internet Explorer 5 and up at 800x600 resolution

Notice: The articles in this website are meant for information and education purposes only and are not intended to encourage self-diagnosis and self-medication. Readers should consult their physicians for professional medical advice. 

Copyright © 2006, Medical Observer. All rights reserved.